18. Application: drug screening
References:
1. Baker LA, Tiriac H, Clevers H, Tuveson DA. Modeling pancreatic cancer with organoids. Trends Cancer. 2016 Apr;2(4):176-190. PubMed PMID: 27135056; PubMed Central PMCID: PMC4847151.
2. Francies HE, Barthorpe A, McLaren-Douglas A, Barendt WJ, Garnett MJ. Drug Sensitivity Assays of Human Cancer Organoid Cultures [published correction appears in Methods Mol Biol. 2018 Mar 27;:]. Methods Mol Biol. 2019;1576:339–351.
3. Ponz-Sarvise M, Corbo V, Tiriac H, Engle DD, Frese KK, Oni TE, Hwang CI, Öhlund D, Chio IIC, Baker LA, Filippini D, Wright K, Bapiro TE, Huang P, Smith P, Yu KH, Jodrell DI, Park Y, Tuveson DA. Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Clin Cancer Res. 2019 Nov 15;25(22):6742-6755.